logo
Is It Really More Affordable to Shop at Trader Joe's? We Did The Math to Find Out

Is It Really More Affordable to Shop at Trader Joe's? We Did The Math to Find Out

CNET11-06-2025
Trader Joe's has a devoted fan base that keeps coming back for more of its unique products, upbeat employees and low prices. But, we began to wonder if the grocery deals are as good as they are made out to be? Sometimes the savings seem too good to be true, so there must be a catch, right? As a food writer and deal seeker, I set out to find out.
After comparing prices on a 48-item grocery list between Trader Joe's and a typical supermarket, the results spoke for themselves. Here's everything to know about comparing the prices at Trader Joe's to other successful chains.
Trader Joe's vs. Stop & Shop Product TJ's Stop & Shop Baby spinach, 6oz $1.99 $3.99 Fresh herbs (variety), 1oz* $1.69 $2.29 Head of cauliflower, each $2.99 $3.49 Red bell pepper, each $1.29 $2.29 Banana, each $0.19 $0.41 Beefsteak tomato, each $1.29 $1.40 Hass avocado, each $1.49 $1.99 Italian extra virgin olive oil, 33.8oz* $5.99 $8.29 Honey O's, 13.5oz $2.29 $7.19 Organic unsweetened soy beverage, 32 oz $1.99 $4.19 Classic potato chips, 10oz* $2.49 $5.29 Tortilla chips, 10oz^ $2.49 $3.39 Roasted red pepper hummus, 10oz $3.49 $4.99 Shredded mild cheddar cheese, 12oz* $3.49 $3.19 Cream cheese, 8oz $1.69 $2.89 Sliced Muenster cheese, 12oz* $4.49 $3.79 Greek nonfat yogurt, 32oz $5.49 $5.79 Organic 2% milk, half gallon $3.79 $5.69 Half and half, 1 quart $2.69 $5.19 Unsweetened applesauce, 24oz $1.99 $3.19 Creamy salted peanut butter, 16oz $2.29 $2.59 Whole bean coffee, 14oz* $4.99 $8.39 Whole roasted and salted cashews, 16oz^ $7.99 $16.49 Organic low sodium chicken broth, 32oz $1.99 $3.19 Solid white albacore tuna in olive oil, 5oz $2.29 $2.59 Organic virgin coconut oil, 16oz* $4.99 $14.69 Garbanzo beans, 15oz $0.89 $1.19 Black beans, 15oz $0.89 $1.19 Whole grain Dijon mustard, 12.3oz* $1.99 $3.79 Grade A 100% maple syrup, 8oz $4.49 $9.69 Clover honey, 12oz $3.99 $6.29 Spaghetti, 16oz $0.99 $1.49 Unbleached all-purpose flour, 5lbs $2.99 $3.69 Frozen peas, 16oz $1.59 $3.49 Chopped frozen spinach, 16oz $1.49 $3.49 Frozen pepperoni pizza, 15oz^ $5.99 $7.89 Multigrain waffles, 11oz^ $2.49 $3.29 Large brown eggs, 1 dozen $3.29 $4.19 Frozen cheese tortellini, 10oz^ $2.49 $5.19 15% lean ground beef, 16oz $5.99 $5.49 Fresh Atlantic salmon, 16oz $9.99 $14.99 Ground turkey, 16oz $3.99 $5.49 All natural whole chicken, per pound $3.99 $3.99 Plain bagels, 6 count, 18oz $1.99 $4.39 English muffins, 6 count, 12oz $1.99 $1.99 Flour tortillas, 8 count, 15.5oz $2.99 $2.09 French vanilla ice cream, half gallon $6.49 $3.79 Fresh pizza dough, 16oz $1.49 $3.49
Total $150.32 $227.45 *indicates that Trader Joe's item was of a larger size
^Indicates that Stop & Shop item was of a larger size
My haul from TJ's was about 33% cheaper than the same haul from Stop & Shop, exceeding even my expectations.
For more price comparisons, check out how much you can save by shopping at Costco, if it's cheaper to buy meal kits than groceries and if shopping for groceries online is less expensive than in the store.
Who supplies Trader Joe's products?
First things first. In understanding the potential cost savings of shopping only at Trader Joe's, it's important to know where TJ's products come from, whether we're speaking of flour and butter or Unexpected Cheddar and Butter Chicken. Having previously brought you an analysis of store brand versus name brand products and finding massive potential savings in the grocery receipts, is it simply a matter of Trader Joe's only selling store brand items? That is: Trader Joe's more or less only sells products under its own brand name, with few exceptions.
Trader Joe's is definitely cheaper than the average grocery store, but you might have to wait in a longer checkout line to take advantage of the prices.
Shara Tibken/CNET
Trader Joe's isn't actually a manufacturer unto itself, and unlike some store brands, which are just name brands in disguise, Trader Joe's relationship with its vendors is a unique point in understanding its pricing structure. Turns out there's actually merit to the "trader" element of Trader Joe's, which, according to its website, deals directly with manufacturers and growers, and cuts out the brokers and distributors, contributing to its lower-seeming prices. Which exact vendors make those Trader Joe's items with cult-like followings is a closely guarded secret.
Trader Joe's vs. Stop & Shop
Stop & Shop is a regional chain in the northeastern US whose sibling companies include Hannaford, Giant and Food Lion. I chose Stop & Shop to represent an average grocery chain in my available area whose reputation is good and whose prices are known for being reasonable but which doesn't have the cult following of Trader Joe's, or even certain other conventional retailers such as Wegmans. Stop & Shop does have its own store brand, which is simply called SB, which stands for "store brand." (No points for originality there, Stop & Shop.) It also has an organic store brand line called Nature's Promise. Both the SB and Nature's Promise brands offer a variety of products in every department.
Your local Stop & Shop may have self-driving delivery pods but it also has significantly higher grocery prices than Trader Joe's.
Stop & Shop
How I evaluated Trader Joe's and Stop & Shop for staples
Using grocery shopping templates available online, I generated a list of 48 basic grocery items representing a range of price points from nearly all food and drink departments in October 2022. For each item, I compared the Trader Joe's price, sourced from an in-store visit in Queens, New York, to the Stop & Shop price, sourced from Instacart. (For Stop & Shop items that are typically sold by weight, Instacart offers an estimated price per piece.)
I tried to find equivalencies in terms of the sizes of each product but noted where one store or the other was offering a larger size. I didn't scale the prices accordingly, however, because I wanted the end totals to reflect the actual prices you'd find on your grocery receipts. To make it as fair a fight as possible, and because Trader Joe's entire fleet of products qualifies as store-brand, wherever possible I used the equivalent Stop & Shop SB or Nature's Promise product as a point of comparison.
Trader Joe's beloved pepita salsa is just one example of a store brand item that's gained fandom and loyalty all its own.
Trader Joe's
Trader Joe's savings are still huge
At the end of the nearly 50-item list of basic staples, comparing what was effectively store brand to store brand, Trader Joe's clearly came out as the winner, totaling only $150.32 to Stop & Shop's $227.45, for a total of about 33% savings on the entirety of the list. If you're someone who doesn't typically purchase store brand items when shopping at conventional grocery stores, it is safe to assume that the potential savings would be even greater, easily approaching a 50% discount compared with similar brand name products.
Where are the biggest savings on Trader Joe's items?
Almost all of Trader Joe's biggest money savers come from the pantry department, with cereal, soy milk, coffee, maple syrup, coconut oil and nuts amounting to more than 50% off of the Stop & Shop price. Coffee and coconut oil, in particular, have such untouchable prices, one wonders whether TJ's has brokered a deal with the devil himself.
It is worth noting that deli cheeses seemed to be the one category where Stop & Shop came close to TJ's. Stop & Shop's prices for both shredded cheddar cheese and sliced Muenster cheese were actually lower than the same TJ's products. In both cases the sizes offered by Stop & Shop were smaller, however, giving TJ's an advantage in terms of value, but it stands to reason that for items with shorter shelf lives, such as cheese, the smaller package might be a more advantageous purchase anyway.
Cheese and produce are two departments where Trader Joe's may not always have a clear price advantage.
Getty Images
Additionally, the produce department at Trader Joe's is almost entirely sold by package or by item (as opposed to by weight), with prices that rarely fluctuate, meaning that there might be better produce deals to be found at conventional retailers for fruits and vegetables that are priced by weight rather than the piece, and based on seasonality. (When spotted, I will always buy a 99 cent avocado at any retailer.)
I would also note that weekly sales specials, which were not necessarily factored in here, can also offer a conventional retailer a price advantage over Trader Joe's on certain items from week to week. Despite these possibilities for occasional better savings in some departments, however, the math is clear: Trader Joe's has some of the best overall prices, even where basic groceries are concerned.
This story was originally published in October 2022.
FAQs
What grocery store did we use as the point of comparison with Trader Joe's?
We used Stop & Shop prices as the direct comparison to Trader Joe's. The difference between prices for Stop & Shop items and Trader Joe's items is how we generated the results used in this article. Your mileage may vary when comparing Trader Joe's prices to other grocery stores.
Why are Trader Joe's items so cheap?
Trader Joe's has a unique relationship with manufacturers, allowing them to cut out the middleman in the supply chain -- TJ's is then able to pass some of those savings on to you, the consumer, as they sell their products at a lower overall price.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share
XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share

Yahoo

time21 minutes ago

  • Yahoo

XAI Madison Equity Premium Income Fund Declares its Monthly Distribution of $0.060 per Share

CHICAGO, Aug. 01, 2025 (GLOBE NEWSWIRE) -- XAI Madison Equity Premium Income Fund (the 'Fund'), has declared its regular monthly distribution of $0.060 per share on the Fund's common shares (NYSE: MCN) payable on September 2, 2025. The amount represents no change from the previous month's distribution amount. As mentioned in previous distribution declarations, the Fund has changed its distribution frequency from quarterly to monthly, which went into effect with the April 1, 2025 declaration. XA Investments believes this change enables investors to better manage their cash flow needs. Ex-Dividend Date August 15, 2025 Record Date August 15, 2025 Payable Date September 2, 2025 Amount $0.060 per share Change from Previous Month No Change The following dates apply to the declaration: Common share distributions may be paid from net investment income (regular interest and dividends), capital gains and/or a return of capital. The specific tax characteristics of the distributions will be reported to the Fund's common shareholders on Form 1099 after the end of the 2025 calendar year. Shareholders should not assume that the source of a distribution from the Fund is net income or profit. For further information regarding the Fund's distributions, please visit . The Fund's net investment income and capital gain can vary significantly over time; however, the Fund seeks to maintain more stable common share quarterly distributions over time. The Fund's final taxable income for the current fiscal year will not be known until the Fund's tax returns are filed. As a registered investment company, the Fund is subject to a 4% excise tax that is imposed if the Fund does not distribute to common shareholders by the end of any calendar year at least the sum of (i) 98% of its ordinary income (not taking into account any capital gain or loss) for the calendar year and (ii) 98.2% of its capital gain in excess of its capital loss (adjusted for certain ordinary losses) for a one-year period generally ending on December 31 of the calendar year (unless an election is made to use the Fund's fiscal year). In certain circumstances, the Fund may elect to retain income or capital gain to the extent that the Board of Trustees, in consultation with Fund management, determines it to be in the interest of shareholders to do so. The common share distributions paid by the Fund for any particular period may be more than the amount of net investment income from that period. As a result, all or a portion of a distribution may be a return of capital, which is in effect a partial return of the amount a common shareholder invested in the Fund, up to the amount of the common shareholder's tax basis in their common shares, which would reduce such tax basis. Although a return of capital may not be taxable, it will generally increase the common shareholder's potential gain, or reduce the common shareholder's potential loss, on any subsequent sale or other disposition of common shares. Future common share distributions will be made if and when declared by the Fund's Board of Trustees, after the evaluation of several factors, including the Fund's net investment income, financial performance and available cash. There can be no assurance that the amount or timing of common share distributions in the future will be equal or similar to that described herein or that the Board of Trustees will not decide to suspend or discontinue the payment of common share distributions in the future. The Fund's objective is to achieve a high level of current income and current capital gains, with long-term capital appreciation as a secondary objective. The Fund intends to pursue its objective by investing in a portfolio of common stocks and utilizing an option strategy, primarily by writing (selling) covered call options on a substantial portion of the common stocks in the portfolio in order to generate current income and gains from option writing premiums and, to a lesser extent, from dividends. Market action can impact dividend issuance as the Fund's total assets affect the Fund's future dividend prospects. The Fund provides additional information on its website at . About XA Investments XA Investments LLC ('XAI') serves as the Fund's investment adviser. XAI is a Chicago-based firm founded by XMS Capital Partners in 2016. XAI serves as the investment adviser for two listed closed-end funds and an interval closed-end fund. The listed closed-end funds, the XAI Octagon Floating Rate & Alternative Income Trust and XAI Madison Equity Premium Income Fund both trade on the New York Stock Exchange and the interval fund, Octagon XAI CLO Income Fund is available via direct subscription and through select broker/dealers and wealth management platforms. In addition to investment advisory services, the firm also provides investment fund structuring and consulting services focused on registered closed-end funds to meet institutional client needs. XAI offers custom product build and consulting services, including development and market research, sales, marketing, and fund management. XAI believes that the investing public can benefit from new vehicles to access a broad range of alternative investment strategies and managers. XAI provides individual investors with access to institutional-caliber alternative managers. For more information, please visit . About XMS Capital Partners XMS Capital Partners, LLC, established in 2006, is a global, independent, financial services firm providing M&A, corporate advisory and asset management services to clients. It has offices in Chicago, Boston and London. For more information, please visit . About Madison Investments Madison Investments is an independent investment management firm based in Madison, WI. The firm was founded in 1974, has approximately $28.3 billion in assets under management as of March 31, 2025, and is recognized as one of the nation's top investment firms. Madison offers domestic fixed income, U.S. and international equity, covered call, multi-asset, insurance and credit union investment management strategies. For more information, please visit .Madison and/or Madison Investments is the unifying tradename of Madison Investment Holdings, Inc., Madison Asset Management, LLC, and Madison Investment Advisors, LLC. Madison Funds are distributed by MFD Distributor, LLC. Madison is registered as an investment adviser with the U.S. Securities and Exchange Commission. MFD Distributor, LLC is registered with the U.S. Securities and Exchange Commission as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority . XAI does not provide tax advice; please consult a professional tax advisor regarding your specific tax situation. Income may be subject to state and local taxes, as well as the federal alternative minimum tax. Investors should consider the investment objectives and policies, risk considerations, charges and expenses of the Fund carefully before investing. For more information on the Fund, please visit the Fund's webpage at . This press release shall not constitute an offer to sell or a solicitation to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer or solicitation or sale would be unlawful prior to registration or qualification under the laws of such state or jurisdiction. NOT FDIC INSURED NO BANK GUARANTEE MAY LOSE VALUE Media Contact:Kimberly Flynn, PresidentXA Investments LLCPhone: 888-903-3358Email: KFlynn@ in to access your portfolio

US securities regulator announces AI task force
US securities regulator announces AI task force

Yahoo

time21 minutes ago

  • Yahoo

US securities regulator announces AI task force

(Reuters) -The U.S. Securities and Exchange Commission said on Friday that it is creating an artificial intelligence task force to lead the agency's efforts to "enhance innovation and efficiency" in its operations. Valerie Szczepanik, who has been named the SEC's chief AI officer, will lead the task force, the regulator said in a statement. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Yahoo

time21 minutes ago

  • Yahoo

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of its underwritten public offering of 43,700,000 shares of its common stock, which includes the full exercise of the underwriters' option to purchase 5,700,000 additional shares of its common stock, at a public offering price of $3.30 per share. The underwriters did not receive any discounts or commissions with respect to an aggregate of 1,818,181 shares of common stock sold to the Cystic Fibrosis Foundation. All of the shares of common stock in the offering were sold by Prime Medicine. The gross proceeds to Prime Medicine from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $144.2 million. TD Cowen and BMO Capital Markets acted as joint book-running managers for the offering. The shares of common stock were offered by Prime Medicine pursuant to an effective shelf registration statement on Form S-3 that was previously filed with the U.S. Securities and Exchange Commission (SEC) on November 3, 2023 and declared effective by the SEC on November 13, 2023 (File No. 333-275321). The offering was made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A final prospectus supplement relating to and describing the terms of the offering was filed with the SEC and is available on the SEC's website at Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained from TD Securities (USA) LLC, 1 Vanderbilt Avenue, New York, New York 10017, by telephone at (855) 495-9846, or by email at or BMO Capital Markets Corp., Attention: Equity Syndicate Department, 151 West 42nd Street, 32nd Floor, New York, New York 10036, by email at bmoprospectus@ This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction. About Prime Medicine Prime Medicine is a leading biotechnology company dedicated to creating and delivering the next generation of gene editing therapies to patients. The Company is deploying its proprietary Prime Editing platform, a versatile, precise and efficient gene editing technology, to develop a new class of differentiated one-time curative genetic therapies. Prime Editors are designed to make only the right edit at the right position within a gene while minimizing unwanted DNA modifications. Prime Medicine is currently progressing a diversified portfolio of investigational therapeutic programs organized around our core areas of focus: liver, lung, and immunology and oncology. Across each core area, Prime Medicine is focused initially on a set of high value programs, each targeting a disease with well-understood biology and a clearly defined clinical development and regulatory path. Investor and Media ContactsGregory DearbornPrime Medicine857-209-0696gdearborn@ Hannah DeresiewiczPrecision

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store